Evidence map›Paper›PMID 26185770›Full record

ArticleJournal of immunology research2015

IFI16 Expression Is Related to Selected Transcription Factors during B-Cell Differentiation.

Pier Paolo Piccaluga, Claudio Agostinelli, Fabio Fuligni, Simona Righi, Claudio Tripodo, Maria Carla Re, Alberto Clò, Anna Miserocchi, Silvia Morini, Marisa Gariglio and 7 more

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Review
  3. Integrated multiomic analyses: An approach to improve understanding of diabetic kidney disease.Diabetic medicine : a journal of the British Diabetic Association · 2025
    Review
  4. Article
  5. Cells · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Transcription factor NF-κB promotes acute lung injuryThe Journal of biological chemistry · 2020
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 1 country.

Pier Paolo PiccalugaDepartment of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Hematopathology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy.
Claudio AgostinelliDepartment of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Hematopathology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy.
Fabio FuligniDepartment of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Hematopathology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy.
Simona RighiDepartment of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Hematopathology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy.
Claudio TripodoDepartment of Human Pathology, University of Palermo, 90127 Palermo, Italy.
Maria Carla ReDepartment of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Microbiology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy.
Alberto ClòDepartment of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Microbiology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy.
Anna MiserocchiDepartment of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Microbiology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy.
Silvia MoriniDepartment of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Microbiology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy.
Marisa GariglioDepartment of Clinical and Experimental Medicine, Medical School of Novara, 28100 Novara, Italy.
Gian Gaetano FerriDepartment of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Otolaryngology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy.
Alberto Rinaldi-CeroniDepartment of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Otolaryngology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy.
Ottavio PiccinDepartment of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Otolaryngology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy.
Marco De AndreaDepartment of Public Health and Microbiology, University of Turin, 10126 Turin, Italy.
Stefano A PileriDepartment of Experimental, Diagnostic, and Specialty Medicine, Bologna University Medical School Unit of Hematopathology, S. Orsola Malpighi Hospital, 40138 Bologna, Italy.
Santo LandolfoDepartment of Public Health and Microbiology, University of Turin, 10126 Turin, Italy.
Davide GibelliniDepartment of Pathology and Diagnostic, University of Verona, 35124 Verona, Italy.
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITUniversity of Turin · ITUniversity of Palermo · ITUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interferon-inducible DNA sensor IFI16 is involved in the modulation of cellular survival, proliferation, and differentiation. In the hematopoietic system, IFI16 is consistently expressed in the CD34+ stem cells and in peripheral blood lymphocytes; however, little is known regarding its regulation during maturation of B- and T-cells. We explored the role of IFI16 in normal B-cell subsets by analysing its expression and relationship with the major transcription factors involved in germinal center (GC) development and plasma-cell (PC) maturation. IFI16 mRNA was differentially expressed in B-cell subsets with significant decrease in IFI16 mRNA in GC and PCs with respect to naïve and memory subsets. IFI16 mRNA expression is inversely correlated with a few master regulators of B-cell differentiation such as BCL6, XBP1, POU2AF1, and BLIMP1. In contrast, IFI16 expression positively correlated with STAT3, REL, SPIB, RELA, RELB, IRF4, STAT5B, and STAT5A. ARACNE algorithm indicated a direct regulation of IFI16 by BCL6, STAT5B, and RELB, whereas the relationship between IFI16 and the other factors is modulated by intermediate factors. In addition, analysis of the CD40 signaling pathway showed that IFI16 gene expression directly correlated with NF-κB activation, indicating that IFI16 could be considered an upstream modulator of NF-κB in human B-cells.

Indexed as

Cell DifferentiationGene Expression RegulationAdultB-LymphocytesB-Lymphocyte SubsetsEnzyme ActivationFemaleGene Expression ProfilingGerminal CenterHumansLymphoid TissueMaleNF-kappa BNuclear ProteinsPhosphoproteinsPlasma CellsIFI16 protein, humanNF-kappa BNuclear ProteinsPhosphoproteinsRNA, MessengerTranscription Factors

Identifiers

PMID26185770
PMCPMC4491573
OpenAlexW1535400316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.